RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: status epilepticus
Accession: DOID:1824
browse the term
Definition: A prolonged seizure or seizures repeated frequently enough to prevent recovery between episodes occurring over a period of 20-30 minutes. The most common subtype is generalized tonic-clonic status epilepticus, a potentially fatal condition associated with neuronal injury and respiratory and metabolic dysfunction. Nonconvulsive forms include petit mal status and complex partial status, which may manifest as behavioral disturbances. Simple partial status epilepticus consists of persistent motor, sensory, or autonomic seizures that do not impair cognition (see also EPILEPSIA PARTIALIS CONTINUA). Subclinical status epilepticus generally refers to seizures occurring in an unresponsive or comatose individual in the absence of overt signs of seizure activity. (From N Engl J Med 1998 Apr 2;338(14):970-6; Neurologia 1997 Dec;12 Suppl 6:25-30)
Synonyms: exact_synonym: Complex Partial Status Epilepticus; Electrographic Status Epilepticus; Generalized Convulsive Status Epilepticus; Generalized Status Epilepticus; Grand Mal Status Epilepticus; Non Convulsive Status Epilepticus; Petit Mal Status; Simple Partial Status Epilepticus; absence status; grand mal status; subclinical status epilepticus
primary_id: MESH:D013226
xref: EFO:0008526 ; GARD:10191 ; NCI:C85079
For additional species annotation, visit the
Alliance of Genome Resources .
G
Abat
4-aminobutyrate aminotransferase
ISO
RGD
PMID:9344635
RGD:1598522
NCBI chr16:8,331,293...8,439,432
Ensembl chr16:8,331,293...8,439,432
G
Abcb1a
ATP-binding cassette, sub-family B member 1A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:14706787
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
ISO EXP
mRNA:increased expression:dentate gyrus, posterior parahippocampal gyrus (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:14706787 PMID:15380564
RGD:1358367
NCBI chr 5:8,848,147...8,916,314
Ensembl chr 5:8,848,147...8,916,315
G
Abcc2
ATP-binding cassette, sub-family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16504477 PMID:16504477
RGD:1598613
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
G
Abcc8
ATP-binding cassette, sub-family C member 8
ISO
mRNA:decreased expression:hippocampus
RGD
PMID:22050960
RGD:5686281
NCBI chr 7:45,753,952...45,829,441
Ensembl chr 7:45,753,947...45,829,457
G
Abcg2
ATP binding cassette subfamily G member 2 (Junior blood group)
ISO
protein:increased expression:brain, astrocyte
RGD
PMID:16190927
RGD:2315587
NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661
G
Acan
aggrecan
ISO
RGD
PMID:22934955
RGD:11570543
NCBI chr 7:78,702,974...78,764,847
Ensembl chr 7:78,703,231...78,764,847
G
Adam10
a disintegrin and metallopeptidase domain 10
ISO
mRNA:increased expression:dentate gyrus
RGD
PMID:15950787
RGD:1559151
NCBI chr 9:70,586,133...70,687,511
Ensembl chr 9:70,586,279...70,687,511
G
Adam9
ADAM metallopeptidase domain 9
ISO
mRNA:increased expression:dentate gyrus
RGD
PMID:15950787
RGD:1559151
NCBI chr 8:25,439,627...25,507,138
Ensembl chr 8:25,439,627...25,506,943
G
Aif1
allograft inflammatory factor 1
ISO
protein:increased expression:dentate gyrus, brain subventricular zone (rat)
RGD
PMID:17178407
RGD:2313036
NCBI chr17:35,389,967...35,394,977
Ensembl chr17:35,389,967...35,395,044
G
Alad
aminolevulinate, delta-, dehydratase
ISO
protein:decreased activity:hippocampus, frontal cortex (rat)
RGD
PMID:20026167
RGD:4144137
NCBI chr 4:62,422,762...62,438,300
Ensembl chr 4:62,427,406...62,438,155
G
Ank3
ankyrin 3, epithelial
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19306853 PMID:19306853
RGD:6767290
NCBI chr10:69,234,608...69,863,266
Ensembl chr10:69,234,603...69,863,268
G
Apex1
apurinic/apyrimidinic endonuclease 1
ISO
protein:increased expression:brain
RGD
PMID:11852039
RGD:1599366
NCBI chr14:51,162,406...51,164,645
Ensembl chr14:51,162,425...51,164,596
G
Apod
apolipoprotein D
ISO
mRNA:increased expression:hippocampus
RGD
PMID:10372566
RGD:2311203
NCBI chr16:31,115,010...31,133,626
Ensembl chr16:31,115,010...31,133,626
G
Aqp1
aquaporin 1
ISO
RGD
PMID:19619613
RGD:2316077
NCBI chr 6:55,313,284...55,325,540
Ensembl chr 6:55,313,417...55,325,540
G
Aqp4
aquaporin 4
severity
ISO IMP IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20886625 PMID:20886625 PMID:22361023 PMID:22361023
RGD:5148023 , RGD:8695999 , RGD:8695999
NCBI chr18:15,522,451...15,544,039
Ensembl chr18:15,522,553...15,544,039
G
Ascl1
achaete-scute family bHLH transcription factor 1
ISO
RGD
PMID:11564418
RGD:2314147
NCBI chr10:87,326,681...87,329,522
Ensembl chr10:87,326,681...87,329,522
G
Atm
ataxia telangiectasia mutated
ISO
RGD
PMID:11852039
RGD:1599366
NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040
G
Atp2a2
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15288437
NCBI chr 5:122,591,576...122,640,288
Ensembl chr 5:122,591,576...122,640,288
G
Bax
BCL2-associated X protein
treatment
ISO
RGD
PMID:22849356
RGD:10054246
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bcl2
B cell leukemia/lymphoma 2
treatment
ISO
protein:decreased expression:hippocampus
RGD
PMID:18076646 PMID:22842798
RGD:2293065 , RGD:11522734
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Bcl2l1
BCL2-like 1
ISO
mRNA:increased expression:dentate gyrus (rat)
RGD
PMID:24051278
RGD:11352818
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
G
Bdnf
brain derived neurotrophic factor
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:8635431 PMID:8821376 PMID:19366663 PMID:19686240
RGD:4891125 , RGD:5684912
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
G
Becn1
beclin 1, autophagy related
ISO
mRNA:protein:increased expression CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19138675 PMID:19138675
RGD:6483096
NCBI chr11:101,179,084...101,193,112
Ensembl chr11:101,176,778...101,193,112
G
Casp1
caspase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18571097
NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
G
Casp2
caspase 2
disease_progression
ISO
RGD
PMID:17627033
RGD:4107076
NCBI chr 6:42,241,942...42,259,442
Ensembl chr 6:42,241,919...42,259,442
G
Casp3
caspase 3
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16679645 PMID:18571097 PMID:20214503
RGD:10054104
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp6
caspase 6
ISO
protein:increased expression, increased activity:hippocampus
RGD
PMID:15749343
RGD:2301314
NCBI chr 3:129,695,064...129,707,761
Ensembl chr 3:129,695,074...129,707,752
G
Casp8
caspase 8
ISO
protein:increased activity:hippocampus CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18571097 PMID:15036620
RGD:2311439
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
G
Cat
catalase
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:15245787 PMID:15752349 PMID:17383094 PMID:18096215
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Ccl2
C-C motif chemokine ligand 2
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19490431 PMID:20034406 PMID:17950261
RGD:2307057
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccl3
C-C motif chemokine ligand 3
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19490431 PMID:22248156
RGD:8552226
NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
G
Ccl4
C-C motif chemokine ligand 4
ISO
mRNA, protein:increased expression:brain
RGD
PMID:21731074
RGD:5683875
NCBI chr11:83,553,410...83,555,509
Ensembl chr11:83,553,410...83,555,509
G
Ccnd1
cyclin D1
treatment
ISO
RGD
PMID:24051278
RGD:11352818
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
G
Ccr10
C-C motif chemokine receptor 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17181556
NCBI chr11:101,063,824...101,066,269
Ensembl chr11:101,063,823...101,066,269
G
Ccr2
C-C motif chemokine receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19490431 PMID:20034406
NCBI chr 9:123,901,954...123,913,594
Ensembl chr 9:123,901,987...123,913,594
G
Ccr3
C-C motif chemokine receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19490431
NCBI chr 9:123,817,799...123,831,729
Ensembl chr 9:123,822,009...123,831,726
G
Ccr5
C-C motif chemokine receptor 5
ISO
RGD
PMID:22248156
RGD:8552226
NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736
G
Ccr7
C-C motif chemokine receptor 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17181556
NCBI chr11:99,035,025...99,045,903
Ensembl chr11:99,035,022...99,045,903
G
Ccr8
C-C motif chemokine receptor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17181556
NCBI chr 9:119,921,199...119,923,972
Ensembl chr 9:119,921,180...119,923,972
G
Ccr9
C-C motif chemokine receptor 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17181556
NCBI chr 9:123,596,276...123,612,522
Ensembl chr 9:123,507,504...123,613,395
G
Cd40
CD40 antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18455351
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
G
Cdh2
cadherin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12125071
NCBI chr18:16,721,934...16,942,303
Ensembl chr18:16,721,934...16,942,303
G
Cfl1
cofilin 1, non-muscle
treatment
ISO
RGD
PMID:27642592
RGD:11568691
NCBI chr19:5,540,483...5,544,059
Ensembl chr19:5,540,483...5,545,229
G
Ckmt1
creatine kinase, mitochondrial 1, ubiquitous
ISO
RGD
PMID:20979657
RGD:11565113
NCBI chr 2:121,188,257...121,194,218
Ensembl chr 2:121,188,195...121,194,218
G
Cnr1
cannabinoid receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19368833 PMID:19368833
RGD:2314675
NCBI chr 4:33,923,171...33,948,831
Ensembl chr 4:33,924,593...33,948,831
G
Crh
corticotropin releasing hormone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7756609
NCBI chr 3:19,747,565...19,749,560
Ensembl chr 3:19,747,565...19,749,560
G
Crp
C-reactive protein, pentraxin-related
ISO
protein:increased expression:plasma:
RGD
PMID:23398413
RGD:9586015
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Cx3cl1
C-X3-C motif chemokine ligand 1
treatment
ISO
RGD
PMID:21481949
RGD:9491789
NCBI chr 8:95,498,808...95,509,055
Ensembl chr 8:95,498,637...95,509,055
G
Cx3cr1
C-X3-C motif chemokine receptor 1
treatment
ISO
RGD
PMID:21481949
RGD:9491789
NCBI chr 9:119,877,749...119,897,362
Ensembl chr 9:119,877,749...119,898,945
G
Cxcl1
C-X-C motif chemokine ligand 1
ISO
protein:increased expression:brain, neuron, endothelial cell
RGD
PMID:21535896
RGD:5134992
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
G
Cxcl12
C-X-C motif chemokine ligand 12
ISO
protein:increased expression:brain
RGD
PMID:19054393
RGD:2306568
NCBI chr 6:117,145,496...117,158,329
Ensembl chr 6:117,145,496...117,158,328
G
Cyp11a1
cytochrome P450, family 11, subfamily a, polypeptide 1
ISO
Protein:increased expression:brain
RGD
PMID:16780839
RGD:1599696
NCBI chr 9:57,905,307...57,934,314
Ensembl chr 9:57,913,694...57,934,306
G
Dab1
disabled 1
ISO
protein:increased expression:dentate gyrus (rat)
RGD
PMID:17314278
RGD:2317783
NCBI chr 4:103,476,425...104,602,041
Ensembl chr 4:103,476,556...104,602,041
G
Dmd
dystrophin, muscular dystrophy
ISO
protein:decreased expression:piriform cortex CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20886625 PMID:20886625
RGD:5148023
NCBI chr X:81,858,244...84,248,656
Ensembl chr X:81,992,476...84,249,747
G
Dpysl2
dihydropyrimidinase-like 2
treatment
ISO
RGD
PMID:22761705
RGD:10045560
NCBI chr14:67,040,313...67,148,490
Ensembl chr14:67,040,313...67,148,410
G
Eif2ak2
eukaryotic translation initiation factor 2-alpha kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16492139
NCBI chr17:79,157,933...79,190,001
Ensembl chr17:79,159,993...79,190,002
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16492139
NCBI chr 6:70,821,468...70,882,225
Ensembl chr 6:70,821,499...70,882,229
G
Eif2s1
eukaryotic translation initiation factor 2, subunit 1 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15003282
NCBI chr12:78,908,846...78,933,784
Ensembl chr12:78,908,593...78,933,784
G
Elavl4
ELAV like RNA binding protein 4
ISO
mRNA:increased expression:hippocampus:
RGD
PMID:17577668
RGD:9685310
NCBI chr 4:110,060,934...110,209,127
Ensembl chr 4:110,060,919...110,209,106
G
Epo
erythropoietin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16679645 PMID:17166730
NCBI chr 5:137,481,282...137,484,078
Ensembl chr 5:137,481,282...137,531,504
G
Fos
FBJ osteosarcoma oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7984056 PMID:16696126 PMID:18587450 PMID:18988310
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Foxo3
forkhead box O3
IEP
protein:decreased expression:hippocampus,mitochondrion:
RGD
PMID:23278239
RGD:10402198
NCBI chr10:42,057,841...42,152,691
Ensembl chr10:42,057,837...42,152,751
G
Gap43
growth associated protein 43
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10366005
NCBI chr16:42,068,915...42,161,014
Ensembl chr16:42,068,805...42,161,014
G
Gdnf
glial cell line derived neurotrophic factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7854063 PMID:12914250
NCBI chr15:7,839,529...7,867,061
Ensembl chr15:7,840,327...7,867,056
G
Ghsr
growth hormone secretagogue receptor
ISO
mRNA:decreased expression:hippocampus:
RGD
PMID:23129314
RGD:12907502
NCBI chr 3:27,425,500...27,433,384
Ensembl chr 3:27,425,500...27,432,159
G
Gjb6
gap junction protein, beta 6
ISO
mRNA:increased expression:brain
RGD
PMID:12359154
RGD:632751
NCBI chr14:57,360,760...57,370,764
Ensembl chr14:57,360,760...57,371,068
G
Glp1r
glucagon-like peptide 1 receptor
IMP
RGD
PMID:12925848
RGD:1598440
NCBI chr17:31,120,841...31,155,484
Ensembl chr17:31,120,791...31,159,765
G
Gria1
glutamate receptor, ionotropic, AMPA1 (alpha 1)
ISO
protein:decreased expression:hippocampus (rat)
RGD
PMID:19914343 PMID:25457025
RGD:4107719 , RGD:13792697
NCBI chr11:56,902,342...57,221,070
Ensembl chr11:56,902,213...57,221,070
G
Gria2
glutamate receptor, ionotropic, AMPA2 (alpha 2)
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19222700 PMID:25457025
RGD:13792697
NCBI chr 3:80,588,757...80,711,534
Ensembl chr 3:80,588,757...80,710,142
G
Grik1
glutamate receptor, ionotropic, kainate 1
ISO
RGD
PMID:12724156
RGD:1642496
NCBI chr16:87,692,789...88,087,751
Ensembl chr16:87,692,788...88,087,153
G
Grin1
glutamate receptor, ionotropic, NMDA1 (zeta 1)
ISO
RGD
PMID:25457025
RGD:13792697
NCBI chr 2:25,181,189...25,209,199
Ensembl chr 2:25,181,193...25,209,199
G
Grin2a
glutamate receptor, ionotropic, NMDA2A (epsilon 1)
ISO
RGD
PMID:25457025
RGD:13792697
NCBI chr16:9,385,765...9,813,744
Ensembl chr16:9,385,762...9,813,424
G
Grm1
glutamate receptor, metabotropic 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15058486 PMID:17446080
NCBI chr10:10,561,803...10,958,126
Ensembl chr10:10,561,803...10,958,100
G
Grm5
glutamate receptor, metabotropic 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17634364 PMID:18774262
NCBI chr 7:87,233,212...87,784,271
Ensembl chr 7:87,233,376...87,784,115
G
Grm8
glutamate receptor, metabotropic 8
IDA
RGD
PMID:17430409
RGD:6771183
NCBI chr 6:27,275,120...28,135,094
Ensembl chr 6:27,275,118...28,135,177
G
Grn
granulin
ISO
mRNA, protein:increased expression:brain
RGD
PMID:23887054
RGD:10401660
NCBI chr11:102,321,333...102,327,635
Ensembl chr11:102,321,141...102,327,874
G
Gsk3b
glycogen synthase kinase 3 beta
treatment
ISO
RGD
PMID:22761705
RGD:10045560
NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446
G
H2ax
H2A.X variant histone
ISO
protein:increased phosphorylation:brain
RGD
PMID:21613478
RGD:8693708
NCBI chr 9:44,246,012...44,247,374
Ensembl chr 9:44,245,991...44,247,374
G
Hcn1
hyperpolarization activated cyclic nucleotide gated potassium channel 1
ISO
RGD
PMID:21976514
RGD:9686365
NCBI chr13:117,738,856...118,117,564
Ensembl chr13:117,738,856...118,123,954
G
Hmox1
heme oxygenase 1
ISO
protein:increased expression:cerebral cortex (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20971094 PMID:20971094
RGD:4145131
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Hrh3
histamine receptor H3
ISO
mRNA:increased expression:brain
RGD
PMID:16137576
RGD:1626426
NCBI chr 2:179,741,258...179,746,264
Ensembl chr 2:179,741,258...179,746,281
G
Hsd11b1
hydroxysteroid 11-beta dehydrogenase 1
ISO
mRNA:increased expression:hippocampus
RGD
PMID:22050960
RGD:5686281
NCBI chr 1:192,903,917...192,946,345
Ensembl chr 1:192,903,942...192,946,383
G
Hspa1a
heat shock protein 1A
ISO
protein:increased expression:cerebral spinal fluid:
RGD
PMID:22509781
RGD:7257648
NCBI chr17:35,188,335...35,191,132
Ensembl chr17:35,188,166...35,191,132
G
Hspb1
heat shock protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20971094
NCBI chr 5:135,916,773...135,918,417
Ensembl chr 5:135,916,773...135,918,417
G
Htra2
HtrA serine peptidase 2
ISO
protein:increased expression:hippocampus CA1, neuron, cytoplasm (rat)
RGD
PMID:21132459
RGD:5688370
NCBI chr 6:83,028,247...83,031,552
Ensembl chr 6:83,028,247...83,032,254
G
Idh2
isocitrate dehydrogenase 2 (NADP+), mitochondrial
ISO
protein:increased acetylation:hippocampus
RGD
PMID:29778462
RGD:14985255
NCBI chr 7:79,744,594...79,768,356
Ensembl chr 7:79,744,594...79,765,140
G
Il18
interleukin 18
ISO
RGD
PMID:20674684
RGD:4889491
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
G
Il1b
interleukin 1 beta
ISO
mRNA:increased expression:hippocampus (rat)
RGD
PMID:14678765 PMID:22960129
RGD:1626682 , RGD:7204701
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1rn
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19010416
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Il6st
interleukin 6 signal transducer
ISO
mRNA:increased expression:hippocampus (rat)
RGD
PMID:14614900
RGD:1627571
NCBI chr13:112,600,604...112,643,394
Ensembl chr13:112,600,604...112,646,620
G
Jun
jun proto-oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7984056
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
G
Junb
jun B proto-oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7984056
NCBI chr 8:85,703,538...85,705,377
Ensembl chr 8:85,701,113...85,705,347
G
Jund
jun D proto-oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7984056
NCBI chr 8:71,150,389...71,153,265
Ensembl chr 8:71,151,599...71,153,265
G
Kcnc4
potassium voltage gated channel, Shaw-related subfamily, member 4
ISO
mRNA:decreased expression:subiculum, perirhinal cortex, entorhinal cortex (rat)
RGD
PMID:17942314 PMID:20971086
RGD:9686050 , RGD:10411905
NCBI chr 3:107,345,614...107,367,617
Ensembl chr 3:107,345,619...107,366,868
G
Kcnj11
potassium inwardly rectifying channel, subfamily J, member 11
ISO
mRNA:increased expression:hippocampus
RGD
PMID:22050960
RGD:5686281
NCBI chr 7:45,746,545...45,750,215
Ensembl chr 7:45,743,377...45,750,188
G
Kcnk3
potassium channel, subfamily K, member 3
ISO
protein:decreased expression:hippocampus, astrocyte
RGD
PMID:18671295
RGD:2316522
NCBI chr 5:30,745,514...30,782,614
Ensembl chr 5:30,745,514...30,782,615
G
Kcnk5
potassium channel, subfamily K, member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19220408
NCBI chr14:20,190,125...20,231,850
Ensembl chr14:20,190,125...20,231,877
G
Kcnma1
potassium large conductance calcium-activated channel, subfamily M, alpha member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18695509
NCBI chr14:23,342,356...24,055,173
Ensembl chr14:23,339,499...24,064,559
G
Lamp2
lysosomal-associated membrane protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19272430
NCBI chr X:37,488,524...37,545,337
Ensembl chr X:37,490,234...37,545,331
G
Mef2c
myocyte enhancer factor 2C
ISO
mRNA:increased expression:dentate gyrus CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18949272 PMID:18949272
RGD:5131610
NCBI chr13:83,652,136...83,815,197
Ensembl chr13:83,652,153...83,815,199
G
Mfn1
mitofusin 1
ISO
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:27045873
RGD:12436727
NCBI chr 3:32,583,594...32,633,384
Ensembl chr 3:32,583,614...32,633,388
G
Mir21a
microRNA 21a
ameliorates
ISO
RNA:increased expression: hippocampus
RGD
PMID:22019057 PMID:29751355
RGD:41404707 , RGD:41404714
NCBI chr11:86,474,893...86,474,984
Ensembl chr11:86,474,893...86,474,984
G
Mmp9
matrix metallopeptidase 9
ISO
mRNA:increased expression:hippocampus, astrocyte, dendrite
RGD
PMID:17928157
RGD:8547922
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Mtor
mechanistic target of rapamycin kinase
ISO
protein:increased serine phosphorylation:hippocampus
RGD
PMID:23211629 PMID:23724051
RGD:7175521 , RGD:10041026
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
G
Ngf
nerve growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8635431 PMID:8821376
NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329
G
Nlgn1
neuroligin 1
ISO
RGD
PMID:22539981
RGD:9831126
NCBI chr 3:25,475,972...26,387,504
Ensembl chr 3:25,480,379...26,386,609
G
Nlgn2
neuroligin 2
ISO
RGD
PMID:22539981
RGD:9831126
NCBI chr11:69,713,949...69,728,610
Ensembl chr11:69,713,948...69,728,610
G
Nos1
nitric oxide synthase 1, neuronal
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20149694
NCBI chr 5:118,004,904...118,096,905
Ensembl chr 5:117,919,097...118,096,905
G
Nos2
nitric oxide synthase 2, inducible
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20149694
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Npy
neuropeptide Y
ISO
RGD
PMID:19270346
RGD:10448969
NCBI chr 6:49,799,690...49,806,487
Ensembl chr 6:49,799,690...49,806,487
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
treatment
ISO
RGD
PMID:28386312
RGD:13439740
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
ISO
mRNA:decreased expression:hippocampus
RGD
PMID:22050960
RGD:5686281
NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474
G
Nt5e
5' nucleotidase, ecto
ISO
protein:increased activity:cerebral cortex, synaptosome (rat)
RGD
PMID:16274951
RGD:5134344
NCBI chr 9:88,209,662...88,254,142
Ensembl chr 9:88,209,250...88,254,145
G
Ntf3
neurotrophin 3
ISO
CTD Direct Evidence: marker/mechanism RNA:decreased expression: hippocampus
CTD RGD
PMID:8635431 PMID:22019057
RGD:41404707
NCBI chr 6:126,078,375...126,143,703
Ensembl chr 6:126,078,375...126,143,873
G
Ntrk2
neurotrophic tyrosine kinase, receptor, type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8635431 PMID:8821376
NCBI chr13:58,954,363...59,281,782
Ensembl chr13:58,954,383...59,281,784
G
Ntrk3
neurotrophic tyrosine kinase, receptor, type 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8635431
NCBI chr 7:77,825,711...78,228,865
Ensembl chr 7:77,825,707...78,387,760
G
Ogg1
8-oxoguanine DNA-glycosylase 1
ISO
RGD
PMID:18295498
RGD:2317139
NCBI chr 6:113,303,959...113,311,149
Ensembl chr 6:113,303,933...113,312,029
G
Olig2
oligodendrocyte transcription factor 2
ISO
mRNA, protein:decreased expression:white matter of cerebral lobe
RGD
PMID:31415741
RGD:40902837
NCBI chr16:91,016,745...91,025,567
Ensembl chr16:91,022,345...91,025,565
G
Osbpl2
oxysterol binding protein-like 2
treatment
ISO
RGD
PMID:33132826
RGD:41404657
NCBI chr 2:179,758,059...179,804,475
Ensembl chr 2:179,761,099...179,804,473
G
Pcp4
Purkinje cell protein 4
ISO
mRNA,protein:increased expression:brain:
RGD
PMID:20505763
RGD:9850150
NCBI chr16:96,268,806...96,326,993
Ensembl chr16:96,268,806...96,326,993
G
Pgf
placental growth factor
ISO
protein:increased expression:cerebral cortex, hippocampus
RGD
PMID:22079325
RGD:6483774
NCBI chr12:85,213,413...85,224,087
Ensembl chr12:85,213,409...85,224,564
G
Plat
plasminogen activator, tissue
ISO
RGD
PMID:17040480
RGD:6484215
NCBI chr 8:23,247,655...23,272,864
Ensembl chr 8:23,247,743...23,272,860
G
Plau
plasminogen activator, urokinase
IMP ISO
mRNA, protein:increased expression:hippocampus (rat)
RGD
PMID:20026272 PMID:17040480 PMID:19527776
RGD:6483805 , RGD:6484215 , RGD:6483810
NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
G
Plaur
plasminogen activator, urokinase receptor
ISO
mRNA:increased expression:hippocampus
RGD
PMID:19527776
RGD:6483810
NCBI chr 7:24,161,857...24,175,393
Ensembl chr 7:24,161,909...24,175,393
G
Pnpo
pyridoxine 5'-phosphate oxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19356691
NCBI chr11:96,828,642...96,834,845
Ensembl chr11:96,828,651...96,834,812
G
Polg
polymerase (DNA directed), gamma
ISO
RGD
PMID:18295498
RGD:2317139
NCBI chr 7:79,095,979...79,117,659
Ensembl chr 7:79,095,979...79,116,110
G
Ppp1r1b
protein phosphatase 1, regulatory inhibitor subunit 1B
ISO
protein:increased phosphorylation:brain
RGD
PMID:25219249
RGD:13515071
NCBI chr11:98,239,232...98,248,622
Ensembl chr11:98,239,230...98,248,622
G
Prkcb
protein kinase C, beta
ISO
protein:increased expression:hippocampus
RGD
PMID:15058486
RGD:1625525
NCBI chr 7:121,888,327...122,233,625
Ensembl chr 7:121,887,974...122,233,625
G
Prox1
prospero homeobox 1
ISO
protein:increased expression:dentate gyrus hilus
RGD
PMID:17042797
RGD:5133273
NCBI chr 1:189,850,232...189,903,024
Ensembl chr 1:189,850,232...189,902,911
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18988310 PMID:20643531
RGD:5135057
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Ptk2b
PTK2 protein tyrosine kinase 2 beta
ISO
protein:increased phosphorylation:hippocampus, postsynaptic density CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16600505 PMID:16600505
RGD:1581409
NCBI chr14:66,390,706...66,518,549
Ensembl chr14:66,390,706...66,518,501
G
Ptprz1
protein tyrosine phosphatase receptor type Z, polypeptide 1
ISO
RGD
PMID:10582521
RGD:9589822
NCBI chr 6:22,875,302...23,052,915
Ensembl chr 6:22,875,501...23,052,915
G
Qdpr
quinoid dihydropteridine reductase
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:17366478
RGD:5128581
NCBI chr 5:45,591,374...45,607,571
Ensembl chr 5:45,591,363...45,607,578
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
ISO
protein:increased expression:nucleus, hippocampus
RGD
PMID:17727632
RGD:2298852
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Reln
reelin
ISO
protein:decreased expression:dentate gyrus (rat)
RGD
PMID:17314278
RGD:2317783
NCBI chr 5:22,089,452...22,549,703
Ensembl chr 5:22,089,452...22,549,700
G
Ret
ret proto-oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12914250
NCBI chr 6:118,128,709...118,174,705
Ensembl chr 6:118,128,706...118,174,679
G
Rgs4
regulator of G-protein signaling 4
ISO
RGD
PMID:19126440
RGD:13524534
NCBI chr 1:169,569,046...169,575,211
Ensembl chr 1:169,569,046...169,575,211
G
Scn8a
sodium channel, voltage-gated, type VIII, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19306853
NCBI chr15:100,766,600...100,943,819
Ensembl chr15:100,767,739...100,943,819
G
Slc12a5
solute carrier family 12, member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20600929
NCBI chr 2:164,802,766...164,841,651
Ensembl chr 2:164,802,722...164,841,651
G
Slc18a3
solute carrier family 18 (vesicular monoamine), member 3
IMP
RGD
PMID:18394802
RGD:5686685
NCBI chr14:32,184,394...32,186,807
Ensembl chr14:32,184,395...32,186,807
G
Slc6a8
solute carrier family 6 (neurotransmitter transporter, creatine), member 8
ISO
RGD
PMID:20979657
RGD:11565113
NCBI chr X:72,716,739...72,726,108
Ensembl chr X:72,716,756...72,726,108
G
Slc8a1
solute carrier family 8 (sodium/calcium exchanger), member 1
ISO
protein:decreased expression:brain CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20888801 PMID:15461673
RGD:2316980
NCBI chr17:81,680,534...82,045,816
Ensembl chr17:81,680,534...82,045,806
G
Slc8a2
solute carrier family 8 (sodium/calcium exchanger), member 2
ISO
RGD
PMID:15461673
RGD:2316980
NCBI chr 7:15,861,540...15,894,988
Ensembl chr 7:15,863,751...15,894,988
G
Slc8a3
solute carrier family 8 (sodium/calcium exchanger), member 3
ISO
protein:decreased expression:brain CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20888801 PMID:15461673
RGD:2316980
NCBI chr12:81,244,686...81,380,506
Ensembl chr12:81,244,689...81,379,954
G
Snta1
syntrophin, acidic 1
ISO
protein:decreased expression:piriform cortex CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20886625 PMID:20886625
RGD:5148023
NCBI chr 2:154,218,234...154,250,004
Ensembl chr 2:154,218,233...154,250,019
G
Socs3
suppressor of cytokine signaling 3
ISO
mRNA:increased expression:hippocampus
RGD
PMID:14614901
RGD:1625688
NCBI chr11:117,856,905...117,860,192
Ensembl chr11:117,856,905...117,860,873
G
Sod2
superoxide dismutase 2, mitochondrial
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:25333348
RGD:11035304
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Src
Rous sarcoma oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16600505 PMID:16600505
RGD:1581409
NCBI chr 2:157,265,828...157,313,758
Ensembl chr 2:157,260,364...157,313,782
G
Sstr1
somatostatin receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18951627
NCBI chr12:58,258,524...58,262,822
Ensembl chr12:58,258,558...58,260,673
G
Sstr2
somatostatin receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18951627
NCBI chr11:113,510,153...113,516,854
Ensembl chr11:113,510,168...113,516,854
G
Sstr3
somatostatin receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18951627
NCBI chr15:78,421,214...78,433,565
Ensembl chr15:78,421,208...78,428,885
G
Sstr4
somatostatin receptor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18951627 PMID:18951627
RGD:2324996
NCBI chr 2:148,237,297...148,238,684
Ensembl chr 2:148,237,264...148,238,687
G
Sstr5
somatostatin receptor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18951627
NCBI chr17:25,708,849...25,716,262
Ensembl chr17:25,708,847...25,733,577
G
Tfam
transcription factor A, mitochondrial
ISO
RGD
PMID:21854834
RGD:6767574
NCBI chr10:71,061,298...71,074,157
Ensembl chr10:71,061,294...71,074,110
G
Tnf
tumor necrosis factor
ISO
protein:increased expression:brain CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18455351 PMID:20649973
RGD:4143383
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Vegfa
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17533168
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
G
Xrn2
5'-3' exoribonuclease 2
ISO
mRNA:increased expression:hippocampus (rat)
RGD
PMID:26869208
RGD:11041797
NCBI chr 2:146,854,672...146,919,922
Ensembl chr 2:146,854,916...146,919,920
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all